Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever
Journal article
Salerno-Gonçalves R. et al, (2022), Cellular Immunology, 378
Addressing vaccine inequities among Ukrainian refugees.
Journal article
Hill M. et al, (2022), Lancet Infect Dis, 22, 935 - 936
Effect of childhood vaccination and antibiotic use on pneumococcal populations and genome-wide associations with disease among children in Nepal: an observational study.
Journal article
Kandasamy R. et al, (2022), Lancet Microbe, 3, e503 - e511
Systematic review of host genomic biomarkers of invasive bacterial disease: Distinguishing bacterial from non-bacterial causes of acute febrile illness.
Journal article
Kelly E. et al, (2022), EBioMedicine, 81
Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials
Journal article
Billard MN. et al, (2022), Journal of Clinical Epidemiology, 147, 11 - 20
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
Journal article
Marchevsky NG. et al, (2022), EBioMedicine, 81
Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus.
Journal article
Sheerin D. et al, (2022), Cell Biosci, 12
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
Journal article
Li G. et al, (2022), Lancet, 399, 2212 - 2225
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.
Journal article
Rollier CS. et al, (2022), Vaccine
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
Journal article
Tuekprakhon A. et al, (2022), Cell
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
Journal article
Li Y. et al, (2022), The Lancet, 399, 2047 - 2064
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
Journal article
Nutalai R. et al, (2022), Cell
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial
Journal article
MAIDEN M. et al, (2022), Vaccine
Future reporting of vaccine uptake needs to include any change in ethnic or socioeconomic disparities.
Journal article
Hoang U. et al, (2022), BMJ, 377
Innovative vaccine approaches—a Keystone Symposia report
Journal article
Cable J. et al, (2022), Annals of the New York Academy of Sciences, 1511, 59 - 86
Identification of host-pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank.
Journal article
Mentzer AJ. et al, (2022), Nat Commun, 13
National rates and disparities in childhood vaccination and vaccine-preventable disease during the COVID-19 pandemic: English sentinel network retrospective database study.
Journal article
Hoang U. et al, (2022), Arch Dis Child
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR.
Journal article
Ratcliff J. et al, (2022), J Clin Microbiol
Decoupling of omicron variant infections and severe COVID-19
Journal article
Madhi SA. et al, (2022), The Lancet, 399, 1047 - 1048